NasdaqGM:OMERPharmaceuticals
How Omeros’ (OMER) Noncash-Boosted Q1 Profit Swing Will Impact Investors
Omeros Corporation reported past first-quarter 2026 results showing sales of US$9.89 million and a shift from a net loss to net income of US$56.06 million, with both basic and diluted earnings per share turning positive versus the prior year.
Beyond the headline profit swing, the quarter reflects earnings power influenced by noncash items and comes alongside ongoing regulatory and clinical momentum for YARTEMLEA and the broader complement pipeline.
We’ll now examine how this sharp earnings...

